Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Filed Sep 16, 2021 · 10-K · 78 days after period end · 0001493152-21-022851
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|
| Revenue | $1.61M | — |
| Net Income | -$853.00K | -$1.84M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Sep 16, 2021 · 78 d after period end
